Mepivacaine-Tramadol on the Success of Inferior Alveolar Nerve Block in Symptomatic Irreversible Pulpitis

• Status: Completed
• Trial end date: 2014-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the success of inferior alveolar nerve block, after the local application of Mepivacaine plus Tramadol in patients with symptomatic irreversible pulpitis. Also, to evaluate the duration of the anesthetic effect when using Mepivacaine plus Tramadol in the same anesthetic technique and patients group.

Hypothesis:

Local application of mepivacaine plus tramadol increases the successful of inferior alveolar nerve block in patients with irreversible pulpitis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Daniel Chavarría Bolaños
• Treatments: Epinephrine; Mepivacaine; Tramadol

Criteria

Inclusion Criteria:

• Subjects diagnosed with symptomatic irreversible pulpitis in the first and second mandibular molars.

Exclusion Criteria:

• Pregnancy

• Hypersensitivity to local anesthetics and Tramadol

• Teeth with insufficient tooth structure for restoration, periodontal disease, root resorption, root fracture

• Systemic diseases: diabetes, uncontrolled hypertension.

• Patients taking drugs or narcotics.

• Patients who have used analgesics in the last 8 hours.

• Patients ingested IMAOS and tricyclic antidepressants 14 days before.

• Patients ingested carbamazepine (anticonvulsants)

• Patients in active treatment with ketoconazole and erythromycin.